Clinical Outcomes of Patients Treated With Idarucizumab for Dabigatran Reversal versus Four-factor Prothrombin Complex Concentrate for Warfarin Reversal

被引：0
|
作者：
Clare, Ryan
Hekimian, Avetis
Rafie, Reza
Kim, Cy
Shen, Albert Y.
Lee, Mingsum
机构：
来源：
CIRCULATION | 2017年 / 136卷
关键词：
Anticoagulation;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
16796
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Four-factor prothrombin complex concentrate versus andexanet alfa for direct oral anticoagulant reversal
    Koo, Soo Jin
    Hussain, Yunus
    Booth, Deborah Y.
    Desai, Payal
    Oh, Elly S.
    Rios, Jose
    Audley, Kristen
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2024, 64 (02) : 395 - 401
  • [22] EVALUATION OF FIXED-DOSE FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE FOR EMERGENT WARFARIN REVERSAL IN PATIENTS WITH INTRACRANIAL HEMORRHAGE
    Scott, Rachael
    Kersten, Brian
    Basior, Jeanne
    Nadler, Megan
    JOURNAL OF EMERGENCY MEDICINE, 2018, 54 (06): : 861 - 865
  • [23] FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE FOR CARDIAC SURGERY BLEEDING OR ANTICOAGULATION REVERSAL
    Ahuja, Tania
    Li, Yihan
    Papadopoulos, John
    Pashun, Raymond
    Merchan, Cristian
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [24] Evaluation of three-factor prothrombin complex concentrate versus four-factor prothrombin complex concentrate for the urgent reversal of oral anticoagulation.
    Truong, Shawna
    Snyder, Julie
    Celmins, Laura
    PHARMACOTHERAPY, 2017, 37 (06): : E47 - E47
  • [25] COLLABORATIVE PRESCRIBING OF FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE FOR EMERGENT ANTICOAGULATION REVERSAL
    Tran, Kenneth K.
    Telford, Evan D.
    Hendrickson, Andrew L.
    Franck, Andrew
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 2136 - 2136
  • [26] Inactivated Four-Factor Prothrombin Complex Concentrate Dosing Practices for Reversal of Warfarin-Related Intracranial Hemorrhage
    Denise H. Rhoney
    Mary La
    Molly Merz
    Aaron Cook
    Kent A. Owusu
    Christina Roels
    Joe Blunck
    Justin Shewmaker
    Kiranpal S. Sangha
    Salia Farrokh
    John Lewin
    Kathleen W. Chester
    Theresea Human
    Kathleen Bledsoe
    Kristy Greene
    Melissa Levesque
    Jody C. Rocker
    Gary Davis
    Ron Neyens
    Timothy F. Lassiter
    Sarah M. Adriance
    Neurocritical Care, 2021, 35 : 130 - 138
  • [27] In vivo reversal of the anticoagulant effect of rivaroxaban with four-factor prothrombin complex concentrate
    Barco, Stefano
    Cheung, Y. Whitney
    Coppens, Michiel
    Hutten, Barbara A.
    Meijers, Joost C. M.
    Middeldorp, Saskia
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 172 (02) : 255 - 261
  • [28] Emergent reversal of oral factor Xa inhibitors with four-factor prothrombin complex concentrate
    Lipari, Louis
    Yang, Sam
    Milligan, Brian
    Blunck, Joseph
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2020, 38 (12): : 2641 - 2645
  • [29] Inactivated Four-Factor Prothrombin Complex Concentrate Dosing Practices for Reversal of Warfarin-Related Intracranial Hemorrhage
    Rhoney, Denise H.
    La, Mary
    Merz, Molly
    Cook, Aaron
    Owusu, Kent A.
    Roels, Christina
    Blunck, Joe
    Shewmaker, Justin
    Sangha, Kiranpal S.
    Farrokh, Salia
    Lewin, John
    Chester, Kathleen W.
    Human, Theresea
    Bledsoe, Kathleen
    Greene, Kristy
    Levesque, Melissa
    Rocker, Jody C.
    Davis, Gary
    Neyens, Ron
    Lassiter, Timothy F.
    Adriance, Sarah M.
    NEUROCRITICAL CARE, 2021, 35 (01) : 130 - 138
  • [30] Evaluation of fixed dose four-factor prothrombin complex concentrate for warfarin reversal at a level 1 trauma center
    H Drone
    J Jancik
    J Gorlin
    M McCarthy
    Critical Care, 19 (Suppl 1):
12345